Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Alzheimers Disease Diagnostic Companies

Several companies are actively involved in the development and production of diagnostic tools for Alzheimer's disease. These tools include imaging technologies, blood tests, and other methods for detecting and diagnosing Alzheimer's disease.

Latest Alzheimers Disease Diagnostic Companies Updates:

Roche Holding AG (Switzerland) Received FDA clearance for its Elecsys Tau and P-tau 181 CSF assays, enabling earlier and more accurate detection of Alzheimer's pathology (Jan 2024).

Lilly and Company (US) Initiated Phase 3 trial for its investigational blood test, PrecivityAD™, to detect Alzheimer's disease through amyloid and tau protein biomarkers (Dec 2023).

C2N Diagnostics (US) Completed successful pilot study of its C2N-Tau blood test for early detection of Alzheimer's disease, demonstrating promising results (Nov 2023).Alzheon Announcing positive Phase 2b data for its investigational tau aggregation inhibitor ALZ-801 for the treatment of early Alzheimer's disease (Jan 2024).

BrainStorm Cell Therapeutics Received FDA Fast Track designation for its NurOwn® stem cell therapy for the treatment of moderate Alzheimer's disease (Dec 2023).

List of Alzheimers Disease Diagnostic Key companies in the market:

Eli Lilly and Company

TauRx (Republic of Singapore)

Alector LLC

Accera, Inc.

Treventis Corporation

Neuro-Bio Ltd

Cognition Therapeutics Inc

Hoffmann-La Roche

Novartis AG

Merck & Co.

Alzheimers Disease Diagnostic Market Highlights:

Alzheimers Disease Diagnostic Market Size

Alzheimers Disease Diagnostic Market Trends

Alzheimers Disease Diagnostic Market Analysis

Alzheimers Disease Diagnostic Market Share

Alzheimers Disease Diagnostic Market Highlights:

Alzheimers Disease Diagnostic Market Trends

Alzheimers Disease Diagnostic Market Analysis

Alzheimers Disease Diagnostic Market Share

Alzheimers Disease Diagnostic Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.